VYEPTI

WIPO WIPO 2019

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark VYEPTI was filed as Word mark on 12/18/2019 at the World Intellectual Property Organization.

Trademark Details Last update: July 21, 2023

Trademark form Word mark
File reference 1515762
Countries Afghanistan Antigua and Barbuda Albania Armenia Australia Azerbaijan Bosnia and Herzegovina Bahrain Bonaire, Sint Eustatius and Saba Brazil Botswana Belarus Canada Switzerland China Colombia Cuba Curacao Cyprus Algeria Egypt European Community Georgia Croatia Indonesia India Iran Iceland Japan Kenya Kyrgyzstan Cambodia Kazakhstan Laos Liechtenstein Morocco Monaco Moldova Montenegro Macedonia Mongolia Mexico Namibia Norway New Zealand oa Oman Philippines Serbia Russia Sudan Singapore San Marino São Tomé and Príncipe Sint Maarten Syria Thailand Tajikistan Turkmenistan Tunisia Turkey Ukraine Uzbekistan Vietnam
Base trademark DK No. VA 2019 02380, October 22, 2019
Application date December 18, 2019
Expiration date December 18, 2029

Trademark owner

Ottiliavej 9
2500 VALBY
DK

goods and services

05 Pharmaceuticals and medical preparations and substances; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, dyskinesia, poor or absent motor functions, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP); pharmaceutical preparations and substances for the prevention and treatment of restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; preparations, substances, reagents and agents for diagnostic and medical purposes
10 Surgical and medical apparatus and instruments; devices, syringes and needles for injections and medical purposes; apparatus and instruments for diagnostic purposes including test kits; integrated medical systems containing medical apparatus and software for information and information management for use of a Web-based physical and psychological and neurological examination and assessment of patients and clients at a distance and at a clinic; medical instruments for information, guidance, management and control of medicines

Trademark history

Date Document number Area Entry
July 20, 2023 2023/29 Gaz PH RAW: Total Invalidation
June 1, 2022 2022/23 Gaz CA RAW: Rule 18ter(2)(ii) GP following a provisional refusal
May 19, 2022 2022/24 Gaz MX Rejection
August 12, 2021 2021/34 Gaz CA Rejection
July 27, 2021 2021/30 Gaz TM Rejection
July 15, 2021 2021/29 Gaz TH Rejection
July 7, 2021 2021/28 Gaz KH Rejection
June 1, 2021 2021/25 Gaz Deletion
May 27, 2021 2021/21 Gaz JP Rejection
April 26, 2021 2021/18 Gaz KR Rejection
April 22, 2021 2021/17 Gaz VN Rejection
April 19, 2021 2021/16 Gaz UA Rejection
April 9, 2021 2021/15 Gaz LI Rejection
April 6, 2021 2021/14 Gaz GE Rejection
March 30, 2021 2021/13 Gaz NO Rejection
March 19, 2021 2021/12 Gaz LA Rejection
March 5, 2021 2021/13 Gaz IS Rejection
March 3, 2021 2021/9 Gaz CY Rejection
March 3, 2021 2021/10 Gaz CO RAW: Rule 18ter(2)(i) GP following a provisional refusal
March 2, 2021 2021/9 Gaz BR Rejection
February 19, 2021 2021/8 Gaz AM Rejection
February 19, 2021 2021/7 Gaz CU Rejection
February 16, 2021 2021/7 Gaz BA Rejection
February 1, 2021 2021/5 Gaz IN Rejection
January 29, 2021 2021/5 Gaz ME Rejection
January 27, 2021 2021/8 Gaz OA Rejection
January 26, 2021 2021/4 Gaz TJ Rejection
January 26, 2021 2021/4 Gaz MD Rejection
January 20, 2021 2021/3 Gaz CH Rejection
January 11, 2021 2021/2 Gaz DZ Rejection
January 11, 2021 2021/2 Gaz ID Rejection
December 30, 2020 2021/1 Gaz KG Rejection
December 23, 2020 2020/52 Gaz KZ Rejection
December 18, 2020 2020/52 Gaz NA Rejection
December 1, 2020 2020/49 Gaz NZ Rejection
November 27, 2020 2020/48 Gaz SG Rejection
November 21, 2020 2020/48 Gaz TR Rejection
November 10, 2020 2020/46 Gaz AU Rejection
November 3, 2020 2020/45 Gaz BY Rejection
October 12, 2020 2020/44 Gaz CW Rejection
October 5, 2020 2020/41 Gaz MN Rejection
September 29, 2020 2020/41 Gaz RU Rejection
September 27, 2020 2020/40 Gaz PH Rejection
September 15, 2020 2020/38 Gaz EM Rejection
September 14, 2020 2020/38 Gaz SM Rejection
September 11, 2020 2020/38 Gaz ST Rejection
August 28, 2020 2020/36 Gaz CN Rejection
August 26, 2020 2020/36 Gaz CO Rejection
August 18, 2020 2020/34 Gaz SX Rejection
August 13, 2020 2020/33 Gaz RS Rejection
August 10, 2020 2020/33 Gaz SY Rejection
July 21, 2020 2020/30 Gaz US Rejection
April 1, 2020 2020/15 Gaz Correction
March 9, 2020 2020/18 Gaz MC Rejection
February 20, 2020 2020/45 Gaz HR Rejection
December 18, 2019 2020/6 Gaz DK Registration

ID: 141515762